Letter Observational Study Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Ppublish 26 citations
PubMed: 33095451 DOI: 10.1002/ajh.26031
Oxygen gradient ektacytometry-derived biomarkers are associated with vaso-occlusive crises and correlate with treatment response in sickle cell disease.
Am J Hematol 96(1):E29-E32
Authors: Minke A E Rab, Celeste K Kanne, Jennifer Bos, Brigitte A van Oirschot, Camille Boisson, Maite E Houwing, Jorn Gerritsma, Erik Teske, Celine Renoux, Jurgen Riedl, Roger E G Schutgens, Marije Bartels, Erfan Nur, Philippe Joly, Romain Fort, Marjon H Cnossen, Richard van Wijk, Philippe Connes, Eduard J van Beers, Vivien A Sheehan
Affiliations
- Central Diagnostic Laboratory-Research, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
- Van Creveldkliniek, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
- Department of Pediatrics Emory University School of Medicine, Children's Healthcare of Atlanta, Atlanta, Georgia, USA.
- Laboratory LIBM EA7424, University of Lyon 1, "Vascular Biology and Red Blood Cell" team, Lyon, France.
- Laboratory of Excellence GR-Ex, Paris, France.
- Department of Pediatric Hematology, Erasmus Medical Center, Rotterdam, The Netherlands.
- Emma Children's Hospital, Pediatric Hematology, Amsterdam University Medical Centers, Amsterdam, The Netherlands.
- Department of Clinical Sciences of Companion Animals, Faculty of Veterinary Medicine, Utrecht University, Utrecht, The Netherlands.
- Laboratory of Biochemistry and Molecular Biology, UF Biochemistry of Red Blood Cell diseases, Est Center of Biology and Pathology, Hospices Civils de Lyon, Lyon, France.
- Result Laboratory, Albert Schweitzer Hospital, Dordrecht, The Netherlands.
- Department of Hematology, Amsterdam University Medical Centers, Amsterdam, The Netherlands.
- Department of Internal Medicine, Hospices Civils de Lyon, Lyon, France.
MeSH
Cells, Hematology, Anemia, Sickle Cell, Biomarkers, Therapeutics, Vaso-Occlusive Crises
Cited by
- Biophysical and rheological biomarkers of red blood cell physiology and pathophysiology. Curr Opin Hematol, 2021
- Multicenter, phase 1 study of etavopivat (FT-4202) treatment for up to 12Â weeks in patients with sickle cell disease. Blood Adv, 2024
- A novel red blood cell deformability biomarker is associated with hemolysis and vaso-occlusive crises in sickle cell disease. Sci Rep, 2025
- Comment on: Oxygen gradient ektacytometry does not predict pain in children with sickle cell anaemia. Br J Haematol, 2022
- Use of the microfluidic impedance red cell assay in sickle cell disease. Blood Adv, 2025
- A novel composition of endogenous metabolic modulators improves red blood cell properties in sickle cell disease. EJHaem, 2024
- Automated Oxygen Gradient Ektacytometry: A Novel Biomarker in Sickle Cell Anemia. Front Physiol, 2021
- Decreased activity and stability of pyruvate kinase in sickle cell disease: a novel target for mitapivat therapy. Blood, 2021
- Effects of Genotypes and Treatment on Oxygenscan Parameters in Sickle Cell Disease. Cells, 2021
- Increased retention of functional mitochondria in mature sickle red blood cells is associated with increased sickling tendency, hemolysis and oxidative stress. Haematologica, 2023
- Revisiting anemia in sickle cell disease and finding the balance with therapeutic approaches. Blood, 2022
- Shear-Stress-Gradient and Oxygen-Gradient Ektacytometry in Sickle Cell Patients at Steady State and during Vaso-Occlusive Crises. Cells, 2022
- Base editing HbS to HbG-Makassar improves hemoglobin function supporting its use in sickle cell disease. Nat Commun, 2025
- Oxygen gradient ektacytometry-derived biomarkers are associated with acute complications in sickle cell disease. Blood Adv, 2024